tetracaine (Pantocaine)
Jump to navigation
Jump to search
Introduction
Tradename: Pontocaine. (tetracaine hydrochloride) Ophthalmic agent:
Indications
- local anesthesia of the eye for:
- diagnostic procedures
- foreign body or suture removal
- paracentesis of the anterior chamber
- short-term procedures involving the cornea or conjunctiva
- spinal anesthesia
- topical anethesia applied to the nose & throat for various diagnostic procedures
- pruritus, superficial injury, skin irritation
Contraindications
- ophthlamic: secondary bacterial infection
Dosage
- 1-2 drops into the eye prior to procedure
- spinal anesthesia: 5-20 mg of 1% solution into subarachnoid space
- saddle block: 2-5 mg of a 1% solution dilute with an equal volume of CSF before administration
- topical to mucous membrane: apply 2% solution as needed; total dose should not exceed 20 mg
Injection: 1% (2 mL) Ointment (ophthalmic): 0.5% (3.75 g) Solution (ophthalmic): 0.5% (1 mL), 0.2%, 0.3%, 1%
Pharmacokinetics
- anesthesia within 25-60 seconds (ophthalmic) or within 3 minutes topical to mucous membranes or spinal anesthesia
- duration of action: up to 15 minutes[2]; 1.5-3 hours[3]
- metabolized by the liver & plasma
- metabolites are excreted in the urine
elimination via liver
elimination via plasma
elimination via kidney
Adverse effects
- not common (1-10%)
- uncommon (< 1%)
- methemoglobinemia in infants, tenderness, urticaria, edema, urethritis
- prolonged use has been associated with:
- severe keratitis
- corneal opacification
Mechanism of action
- blocks both the initiation & conduction of nerve impulses
More general terms
Component of
- oxymetazoline/tetracaine
- mineral oil/tetracaine
- benzocaine/lidocaine/tetracaine
- lidocaine/tetracaine (Synera)
- benzocaine/tetracaine
- benzocaine/benzalkonium chloride/butyl aminobenzoate/tetracaine (Cetacaine)
References
- ↑ The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- ↑ 2.0 2.1 Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
- ↑ 3.0 3.1 Kaiser Permanente Northern California Regional Drug Formulary, 1998
- ↑ Deprecated Reference